Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260709070112N1Phase 3Not yet recruiting
Phase 3, double-blind trial of promethazine and alprazolam in anxiety disorder (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Stress level before and after sedation, Blood pressure before and after sedation and 3 more. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260709070112N1.